当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析

国药股份

(600511)

  

流通市值:157.81亿  总市值:215.18亿
流通股本:5.53亿   总股本:7.55亿

国药股份(600511)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润4.92亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2082689.40万元,未分配利润1525743.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产3617620.81万元,负债1534931.41万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入13,555,320,492.9752,468,280,576.7239,381,301,380.2725,633,950,652.46
营业总成本13,016,129,612.7750,383,129,082.2937,808,187,653.7624,641,402,034.11
其他经营收益
营业利润606,590,612.272,621,664,012.241,945,535,747.921,229,118,756.21
利润总额606,781,074.392,600,142,573.341,933,742,465.131,226,579,932.03
净利润491,514,664.762,089,403,5861,555,894,465.78991,483,406.86
每股收益
其他综合收益27,155,628.3423,638,059.925,861,163.15337,686.56
综合收益总额518,670,293.12,113,041,645.91,581,755,628.93991,821,093.42
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计31,311,243,404.8931,991,463,386.0930,528,913,480.0330,259,719,678.33
非流动资产:
非流动资产合计4,864,964,735.134,693,560,596.54,596,247,754.964,538,577,861.62
资产总计36,176,208,140.0236,685,023,982.5935,125,161,234.9934,798,297,539.95
流动负债:
流动负债合计14,354,668,111.2415,402,138,852.0814,200,537,627.2314,382,535,357.67
非流动负债:
非流动负债合计994,646,009.15974,661,403.98993,902,979.981,071,518,759.23
负债合计15,349,314,120.3916,376,800,256.0615,194,440,607.2115,454,054,116.9
所有者权益(或股东权益):
归属于母公司股东权益合计19,046,139,042.1218,544,719,561.4818,042,614,851.3417,473,373,453.01
股东权益合计20,826,894,019.6320,308,223,726.5319,930,720,627.7819,344,243,423.05
负债和股东权益合计36,176,208,140.0236,685,023,982.5935,125,161,234.9934,798,297,539.95
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计12,127,754,743.4557,325,496,880.7940,190,830,933.2326,101,716,608.68
经营活动现金流出小计15,720,705,538.8555,319,979,368.7342,241,263,715.3427,612,151,445.48
经营活动产生的现金流量净额-3,592,950,795.42,005,517,512.06-2,050,432,782.11-1,510,434,836.8
投资活动产生的现金流量:
投资活动现金流入小计3,099,356.0750,805,688.9632,545,348.4732,502,299.84
投资活动现金流出小计6,420,132.868,194,378.1740,419,863.9420,579,477.2
投资活动产生的现金流量净额-3,320,776.73-17,388,689.21-7,874,515.4711,922,822.64
筹资活动产生的现金流量:
筹资活动现金流入小计106,000,000319,447,721.2319,447,721.2160,000,000
筹资活动现金流出小计192,664,302.091,706,924,328.711,395,528,475.21,131,724,433.65
筹资活动产生的现金流量净额-86,664,302.09-1,387,476,607.51-1,076,080,754-971,724,433.65
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-3,682,935,874.22600,652,215.34-3,134,388,051.58-2,470,236,447.81
期末现金及现金等价物余额5,209,110,398.088,892,046,272.35,157,006,005.385,821,157,609.15
补充资料:
现金及现金等价物的净增加额-600,652,215.34--2,470,236,447.81
最新报告期:2026-04-24
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中金公司夏璐,张琎,朱言音2.883.15--2026-04-24
华泰证券代雯,孔垂岩,王殷杰2.682.752.832026-04-23
中信建投袁全,刘若飞,沈兴熙,贺菊颖2.863.093.342026-03-31
中金公司夏璐,张琎,朱言音2.883.15--2026-03-23
华泰证券代雯,孔垂岩,王殷杰2.682.752.832026-03-20
TOP↑